VMG Pharmaceuticals Private Limited

VMG Pharmaceuticals Private Limited - pharma in Gurugram, Haryana, India. FY 2026 financials & compliance.
CIN U24100HR2008PTC092142 Incorporated 17 July 2008 ROC Delhi HQ Gurugram, Haryana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹2.17 Cr
▼ 64% YoY
Net loss · FY 2025
₹1.63 Cr
Net margin -74.9%
EBITDA · FY 2025
-₹1.48 Cr
EBITDA margin -68.4%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹11.59 Lakh
Issued & subscribed
Open charges
₹1.51 Cr
Secured borrowings
Company age
18 yrs
Est. 2008
Directors on board
3
As per MCA filings

About VMG Pharmaceuticals Private Limited

Data last updated:

VMG Pharmaceuticals Private Limited is a private limited company based in Gurugram, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 July 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100HR2008PTC092142. Its GSTIN is 06AACCV7777L1ZM (Haryana). The company holds 3 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹11.59 Lakh. It is led by directors including Gauri Pandey and Jose Alejandro Murillo Campos.

Its last annual general meeting (AGM) was held on 24 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Unit No. 807 – 808 Jmd Megapolis Sohan Road Sector – 48, Gurugram, Haryana, India – 122018.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.17 Cr, a decline of 64% compared to the previous year. For the same year it recorded a net loss of ₹1.63 Cr (net margin -74.9%) and EBITDA of -₹1.48 Cr (EBITDA margin -68.4%). Revenue has declined at a compounded annual rate (CAGR) of 45% over three years and 24% over five years.

The company is associated with 1 brand: Vmg pharmaceuticals. As per MCA filings, the company has open charges of ₹1.51 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending. The company has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.33 Cr; the latest was in April 2013. The company has 5 MSME Form 1 returns on record between 2019 and 2022, listing 21 overdue payments to 10 micro and small suppliers.

The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website vmgpharmaceuticals.com.

Company details

CIN U24100HR2008PTC092142
Registration Number 092142
Incorporation Date 17 July 2008
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 24 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Non-Compliant

CIN history

VMG Pharmaceuticals has one previous CIN (Corporate Identification Number): U24100DL2008PTC180997. The current CIN is U24100HR2008PTC092142, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24100HR2008PTC092142Current
U24100DL2008PTC180997Previous

Contact details

VMG Pharmaceuticals Private Limited's registered office is in Gurugram, Haryana. Its website is vmgpharmaceuticals.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Unit No. 807 – 808 Jmd Megapolis Sohan Road Sector – 48, Gurugram, Haryana, India – 122018
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of VMG Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
VMG Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

VMG Pharmaceuticals operates one associated brand: Vmg pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturing and exporting of pharmaceutical products across therapeutic segments in India.vmgpharmaceuticals.com

Business activity

The main business activity of VMG Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of VMG Pharmaceuticals Private Limited, buy the company report.

Financials of VMG Pharmaceuticals Private Limited

FY 2024 filings available

VMG Pharmaceuticals Private Limited reported revenue of ₹2.17 Cr (down 64% YoY) for FY 2025.

Revenue · FY 2025
₹2.17 Cr ▼ 64%
Net loss · FY 2025
₹1.63 Cr margin -74.9%
EBITDA · FY 2025
-₹1.48 Cr margin -68.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 64%
3 years · compounded
▼ 45%
5 years · compounded
▼ 24%
EBITDA CAGR growth
1 year
▼ 68%
3 years · compounded
▼ 62%
5 years · compounded
▼ 26%

Revenue has declined at a compounded annual rate (CAGR) of 24% over five years, including a 64% fall in the latest year. EBITDA fell 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹1.48 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.63 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-68.4%
Net Profit Margin-74.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of VMG Pharmaceuticals Private Limited, buy the company report.

Board of directors of VMG Pharmaceuticals Private Limited

VMG Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Gauri PandeyDirector02 Nov 20187 Years 11 MonthsCurrent
Amita RajeshAdditional Director31 Mar 20197 Years 7 MonthsCurrent
Jose Alejandro Murillo CamposDirector05 Nov 200817 Years 11 MonthsCurrent

Auditor

VMG Pharmaceuticals Private Limited is audited by BAJAJ & GUPTA for the financial year 2024.

Auditor firmFinancial yearFirm registration number
BAJAJ & GUPTAFY 2024011286N

Shareholding

The shareholding of VMG Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of VMG Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.51 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹1.36 Cr
Hdfc Bank Limited₹0.15 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
01 Jan 2024100892669Others₹72 LakhOpen
01 Jan 2024100892044Others₹40 LakhOpen
01 Jan 2024100892040Others₹24 LakhOpen
13 Apr 2022100585601Hdfc Bank Limited₹15 LakhOpen

Total charge records: 4 View all charges

Deals & funding

VMG Pharmaceuticals Private Limited has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.33 Cr; the latest was in April 2013.

Total deals
6
Funding rounds
4
Secondary share transfers
2
Disclosed funding
₹1.33 Cr

Deals on record (5 of 6)

WhenDealAmountParties
Apr 2013Secondary share transferUndisclosedBuyer: 2 individuals
Seller: an individual
Jun 2012Funding round₹31.5 LakhInvestors: an individual
Jan 2012Funding round₹20.7 LakhInvestors: an individual
Jun 2011Funding round₹77 LakhInvestors: an individual
Jun 2011Funding round₹3.6 LakhInvestors: 2 individuals

To see the full deal history of VMG Pharmaceuticals Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

VMG Pharmaceuticals Private Limited has 5 MSME Form 1 returns on record between 2019 and 2022, listing 21 overdue payments to 10 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 10)

SupplierAmount dueDue sinceReported on
an individual supplier
Therdose Pharma Private Limited
Drugfarm Laboratories
Zeiss Pharmaceuticals Private Limited
Global Pharma Healthcare Private Limited

To see the full MSME payment records of VMG Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

VMG Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
06AACCV7777L1ZMHaryanaActive13 Mar 2019

To see the full GST registrations and return filing status of VMG Pharmaceuticals Private Limited, buy the company report.

Recent activity

VMG Pharmaceuticals Private Limited has 7 board changes on record since 2008: 3 appointments and 4 cessations. The latest: Amita Rajesh was appointed as Additional Director on 31 Mar 2019.

AGM
Vmg Pharmaceuticals Private Limited last Annual general meeting of members was held on 24 Sep 2024 as per latest MCA records.
Filing
Vmg Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 72.00 Lakh with Charge ID 100892669 was registered on 01 Jan 2024.
Charges
A charge with Others amounted to Rs. 40.00 Lakh with Charge ID 100892044 was registered on 01 Jan 2024.
Charges
A charge with Others amounted to Rs. 24.00 Lakh with Charge ID 100892040 was registered on 01 Jan 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 15.00 Lakh with Charge ID 100585601 was registered on 13 Apr 2022.
Appointed
Amita Rajesh was appointed as Additional Director.
Ceased
Rajesh Kumar ceased to be Director.
Appointed
Gauri Pandey was appointed as Director.
Ceased
Amita Rajesh ceased to be Director.
Ceased
Murali Gopalan Latteri ceased to be Director.
Ceased
Rashmi Kwatra ceased to be Director.

2 earlier events are in the company report.

Frequently asked questions

VMG Pharmaceuticals is an active private limited company based in Gurugram, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 July 2008 (18+ years old) and is registered under CIN U24100HR2008PTC092142.

VMG Pharmaceuticals has 3 current directors:

The latest financial statements of VMG Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 24 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of VMG Pharmaceuticals is 06AACCV7777L1ZM, registered in Haryana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

The CIN (Corporate Identification Number) of VMG Pharmaceuticals is U24100HR2008PTC092142. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

VMG Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.

VMG Pharmaceuticals was incorporated on 17 July 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.

VMG Pharmaceuticals has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.33 Cr; the latest was in April 2013.

Amita Rajesh was appointed as Additional Director on 31 Mar 2019. Rajesh Kumar ceased to be Director on 31 Mar 2019. Gauri Pandey was appointed as Director on 02 Nov 2018. VMG Pharmaceuticals has 7 board changes on record in total.

VMG Pharmaceuticals has 5 MSME Form 1 returns on record between 2019 and 2022, listing 21 overdue payments to 10 micro and small suppliers. The latest return was filed on 13 May 2022.

VMG Pharmaceuticals can be reached through the website vmgpharmaceuticals.com. Its registered office is in Gurugram, Haryana, India.